Two nights before the data were announced, “transformative” was the word used to describe the results for RASolute 302 ...

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with ...

Results from a late-stage clinical trial of the pill daraxonrasib offer new hope for a notoriously deadly disease, doctors say. In a late-stage trial, an experimental pill called daraxonrasib nearly ...

Share on Pinterest An experimental new pill, daraxonrasib, significantly improved survival rates of participants with pancreatic cancer. Israel Sebastian/Getty Images A new medication performed ...

RASolute 302 findings herald a new standard of care in previously treated patients ...

For decades, scientists have been working to find solutions for pancreatic cancer, which is often diagnosed late and has few ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Early clinical and preclinical results are showing that experimental ...

Pancreatic adenocarcinoma is by far the most common subtype of pancreatic cancer, but there are many other subtypes. Your pancreas is an organ behind your stomach that helps with digestion and hormone ...

Stool changes with pancreatic cancer can include diarrhea, foul-smelling stool, constipation, and changes in stool color. The pancreas is an organ between the stomach and the spine that helps the body ...

When pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the pancreas. In the later stages, pancreatic cancer ...